testosterone cypionate

Generic: testosterone cypionate

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name testosterone cypionate
Generic Name testosterone cypionate
Labeler asclemed usa, inc.
Dosage Form INJECTION
Routes
INTRAMUSCULAR
Active Ingredients

testosterone cypionate 200 mg/mL

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-065
Product ID 76420-065_ead2c72c-bd9f-2f0c-e053-2995a90af3cb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206368
DEA Schedule ciii
Listing Expiration 2026-12-31
Marketing Start 2019-05-31

Pharmacologic Class

Classes
androgen receptor agonists [moa] androgen [epc] androstanes [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420065
Hyphenated Format 76420-065

Supplemental Identifiers

RxCUI
835840
UNII
M0XW1UBI14

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name testosterone cypionate (source: ndc)
Generic Name testosterone cypionate (source: ndc)
Application Number ANDA206368 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 200 mg/mL
source: ndc
Packaging
  • 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10)
source: ndc

Packages (1)

Ingredients (1)

testosterone cypionate (200 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "ead2c72c-bd9f-2f0c-e053-2995a90af3cb", "openfda": {"unii": ["M0XW1UBI14"], "rxcui": ["835840"], "spl_set_id": ["66d4ae28-97c2-42cc-ab5a-a765a623c944"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 mL in 1 VIAL, MULTI-DOSE (76420-065-10)", "package_ndc": "76420-065-10", "marketing_start_date": "20191204"}], "brand_name": "Testosterone Cypionate", "product_id": "76420-065_ead2c72c-bd9f-2f0c-e053-2995a90af3cb", "dosage_form": "INJECTION", "pharm_class": ["Androgen Receptor Agonists [MoA]", "Androgen [EPC]", "Androstanes [CS]"], "product_ndc": "76420-065", "dea_schedule": "CIII", "generic_name": "testosterone cypionate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Testosterone Cypionate", "active_ingredients": [{"name": "TESTOSTERONE CYPIONATE", "strength": "200 mg/mL"}], "application_number": "ANDA206368", "marketing_category": "ANDA", "marketing_start_date": "20190531", "listing_expiration_date": "20261231"}